Company Filing History:
1 out of 1 
1 out of 8 
1 out of 1 
Years Active: 2012-2014
Title: Hirofumi Uto: Innovator in Hepatitis C and Liver Disease Diagnostics
Introduction
Hirofumi Uto is a notable inventor based in Kagoshima, Japan. He has made significant contributions to the field of medical diagnostics, particularly in relation to hepatitis C and liver diseases. With a total of 2 patents, Uto's work has the potential to impact the medical community significantly.
Latest Patents
Uto's latest patents include an agent for inhibiting the production of the hepatitis C virus and a biomarker for the diagnosis of liver disease. The first patent provides an agent that demonstrates notable anti-HCV activity without side effects. This agent comprises a proanthocyanidin polymer composition, which is crucial for developing effective treatments against hepatitis C. The second patent discloses a marker for diagnosing liver disease, which allows for simple determination of the disease. It includes an antibody directed against the marker, a diagnostic agent, and methods for detection in blood or serum. Proteome analysis has shown that the quantities of specific kininogen peptides in patients with non-alcoholic fatty liver disease differ significantly from those in healthy individuals. This innovation enables the identification of chronic hepatitis and asymptomatic virus carriers.
Career Highlights
Throughout his career, Uto has worked with organizations such as the Miyazaki Enterprise Promotion Organization and Miyazaki Prefecture. His experience in these institutions has contributed to his expertise in medical research and innovation.
Collaborations
Uto has collaborated with notable individuals in his field, including Hirohito Tsubouchi and Masahiko Takeshita. These collaborations have likely enhanced his research and development efforts.
Conclusion
Hirofumi Uto's contributions to the fields of hepatitis C treatment and liver disease diagnostics highlight his innovative spirit and dedication to medical science. His patents represent significant advancements that could lead to improved health outcomes for patients.